The pharmaceutical landscape for diabetes is shifting, and transdermal GLP-1 delivery systems represent a promising development. Unlike injections, this method offers a simpler way to deliver GLP-1 therapies. These https://tiannawbyf799951.is-blog.com/47900847/glp-1-patches-a-innovative-approach-to-diabetes-control